期刊
HUMAN GENE THERAPY
卷 28, 期 6, 页码 510-522出版社
MARY ANN LIEBERT, INC
DOI: 10.1089/hum.2016.109
关键词
Tay-Sachs disease; hexosaminidase; intracranial delivery; adeno-associated virus; gene therapy; AAV
资金
- Cure Tay-Sachs Foundation
- National Tay-Sachs and Allied Diseases Association
- National Institutes of Health [U01NS064096]
GM2 gangliosidoses, including Tay-Sachs disease and Sandhoff disease, are lysosomal storage disorders caused by deficiencies in beta-N-acetylhexosaminidase (Hex). Patients are afflicted primarily with progressive central nervous system (CNS) dysfunction. Studies in mice, cats, and sheep have indicated safety and widespread distribution of Hex in the CNS after intracranial vector infusion of AAVrh8 vectors encoding species-specific Hex alpha- or beta-subunits at a 1: 1 ratio. Here, a safety study was conducted in cynomolgus macaques (cm), modeling previous animal studies, with bilateral infusion in the thalamus as well as in left lateral ventricle of AAVrh8 vectors encoding cm Hex alpha- and beta-subunits. Three doses (3.2 x 10(12) vg [n= 3]; 3.2 x 10(11) vg [n= 2]; or 1.1 x 10(11) vg [n= 2]) were tested, with controls infused with vehicle (n= 1) or transgene empty AAVrh8 vector at the highest dose (n= 2). Most monkeys receiving AAVrh8-cmHexa/b developed dyskinesias, ataxia, and loss of dexterity, with higher dose animals eventually becoming apathetic. Time to onset of symptoms was dose dependent, with the highest-dose cohort producing symptoms within a month of infusion. One monkey in the lowest-dose cohort was behaviorally asymptomatic but had magnetic resonance imaging abnormalities in the thalami. Histopathology was similar in all monkeys injected with AAVrh8cm-Hex alpha/beta, showing severe white and gray matter necrosis along the injection track, reactive vasculature, and the presence of neurons with granular eosinophilic material. Lesions were minimal to absent in both control cohorts. Despite cellular loss, a dramatic increase in Hex activity was measured in the thalamus, and none of the animals presented with antibody titers against Hex. The high overexpression of Hex protein is likely to blame for this negative outcome, and this study demonstrates the variations in safety profiles of AAVrh8-Hex alpha/beta intracranial injection among different species, despite encoding for self-proteins.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据